GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » Equity-to-Asset

PharmaRoth Labs (PharmaRoth Labs) Equity-to-Asset : -3.11 (As of Mar. 2011)


View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. PharmaRoth Labs's Total Stockholders Equity for the quarter that ended in Mar. 2011 was $-0.30 Mil. PharmaRoth Labs's Total Assets for the quarter that ended in Mar. 2011 was $0.10 Mil. Therefore, PharmaRoth Labs's Equity to Asset Ratio for the quarter that ended in Mar. 2011 was -3.11.

The historical rank and industry rank for PharmaRoth Labs's Equity-to-Asset or its related term are showing as below:

ROTH's Equity-to-Asset is not ranked *
in the Biotechnology industry.
Industry Median: 0.67
* Ranked among companies with meaningful Equity-to-Asset only.

PharmaRoth Labs Equity-to-Asset Historical Data

The historical data trend for PharmaRoth Labs's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaRoth Labs Equity-to-Asset Chart

PharmaRoth Labs Annual Data
Trend Jun08 Jun09 Jun10
Equity-to-Asset
- - -

PharmaRoth Labs Quarterly Data
Mar07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -10.93 -11.46 -3.11

Competitive Comparison of PharmaRoth Labs's Equity-to-Asset

For the Biotechnology subindustry, PharmaRoth Labs's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharmaRoth Labs's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PharmaRoth Labs's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where PharmaRoth Labs's Equity-to-Asset falls into.



PharmaRoth Labs Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

PharmaRoth Labs's Equity to Asset Ratio for the fiscal year that ended in Jun. 2010 is calculated as

Equity to Asset (A: Jun. 2010 )=Total Stockholders Equity/Total Assets
=-0.292/0
=

PharmaRoth Labs's Equity to Asset Ratio for the quarter that ended in Mar. 2011 is calculated as

Equity to Asset (Q: Mar. 2011 )=Total Stockholders Equity/Total Assets
=-0.295/0.095
=-3.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharmaRoth Labs  (GREY:ROTH) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


PharmaRoth Labs Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of PharmaRoth Labs's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


PharmaRoth Labs (PharmaRoth Labs) Business Description

Traded in Other Exchanges
N/A
Address
8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117
PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines